Arcutis Biotherapeutics
↗Westlake Village, California, United States
Arcutis Biotherapeutics (Nasdaq: ARQT) is a commercial-stage medical dermatology company founded in 2016 with headquarters in Westlake Village, California. The company champions meaningful innovation to address urgent unmet needs in immune-mediated dermatological diseases and conditions. Arcutis is led by a management team with extensive dermatology expertise, having collectively developed more than 50 FDA-approved products. The company employs approximately 342 people and has achieved significant commercial success with its lead product ZORYVE (roflumilast), which generated $372.1M in net product revenue in 2025, representing 123% year-over-year growth. Arcutis operates as a fully commercial-stage organization with multiple FDA approvals and a robust pipeline of topical and oral therapeutic candidates in various stages of development.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Medical Dermatology, Specialty Pharmaceuticals
SIZE & FINANCIALS
Employees:201-500
Revenue:$318M-$372M (2025 product revenue)
Founded:2016
Ownership:public
Status:operating
FUNDING
Stage:Public
Total Raised:$500M+
Investors:HBM Healthcare Investments, Vivo Capital, BlackRock, Omega Funds, Pivotal BioVentures, Goldman Sachs, Frazier Healthcare Partners, Bain Capital Life Sciences, OrbiMed, RA Capital Management
STOCK
Exchange:NASDAQ
Ticker:ARQT
Market Cap:$2.38B
PIPELINE
Stage:Commercial & Phase 1/2
Lead Drug Stage:Commercial
Modalities:Small molecule, Topical cream, Topical foam, PDE4 inhibitor, JAK1 inhibitor, CD200R agonist fusion protein
Active Trials:3
Trial Phases:Phase 1: 1 | Phase 2: 2
FDA Approvals:6
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Kowa Company (commercial partnership for primary care and pediatric practices), Odell Beckham Jr. (brand ambassador partnership, February 2025)
COMPETITION
Position:Emerging Leader
Competitors:Galderma, Janssen Dermatology (Johnson & Johnson), AbbVie, Novartis, Eli Lilly, Pfizer, Amgen, Sanofi +8 more
LEADERSHIP
Key Executives:
Frank Watanabe - President & CEO
Latha Vairavan - Chief Financial Officer
Patrick Burnett, MD, PhD, FAAD - Chief Medical Officer
Todd Edwards - Chief Commercial Officer
Bethany Dudek - Chief Technical Officer
Mas Matsuda, JD - General Counsel
Todd Tucker - Chief Human Resources Officer
Raj Madan, MBA - Chief Digital & Information Officer
Kent Taylor - Senior Vice President, Sales
Mike Injaychock - Vice President Commercial Operations
Scientific Founders:Frank Watanabe (President & CEO, founder perspective)
Board Members:Frank Watanabe (CEO & Board Member), Dan Estes, Ph.D. (Partner, Frazier Healthcare Life Sciences), Patrick Heron (Managing General Partner, Frazier Healthcare Life Sciences), Charles Stiefel, J.D. (Former Chairman & CEO, Stiefel Laboratories), Ricky Sun, Ph.D. (Partner, Bain Capital Life Sciences), Sue-Jean Lin (Board Member, appointed June 2021), Amit Munshi (Board Member, appointed December 2025)
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Arcutis Biotherapeutics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Arcutis Biotherapeutics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.